Русский
Features of pancreas damage in the patients with coronavirus infection
DOI: https://dx.doi.org/10.18565/therapy.2022.7.59-63
Eremina E.Yu., Lityushkina M.I., Strokova O.A.
N.P. Ogarev National Research Mordovia State University, Saransk
Literature
1. Jin X., Lian J.S., Hu J.H. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6): 1002–9. https://dx.doi.org/10.1136/gutjnl-2020-320926. 2. Guan W., Ni Z., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–20.https://dx.doi.org/1056/NEJMoa2002032. 3. Inamdar S., Benias P., Liu Y. et al. Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis. Gastroenterology. 2020; 159(6): 2226–28.e2. https://dx.doi.org/10.1053/j.gastro.2020.08.044. 4. Pan L., Mu M., Yang P. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115(5): 766–73. https://dx.doi.org/10.14309/ajg.0000000000000620. 5. Mao R., Qiu Y., He J. et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5(7): 667–78.https://dx.doi.org/10.1016/S2468-1253(20)30126-6. 6. Cheung K.S., Hung I.F.N., Chan P.P.Y. et al Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. 2020; 159(1): 81–95. https://dx.doi.org/10.1053/j.gastro.2020.03.065. 7. Zhou P., Yang X.L., Wang X.G. et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020.01.22.914952. https://dx.doi.org/10.1101/2020.01.22.914952. 8. Hung I.F., Cheng V.C., Wu A.K. et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004; 10(9): 1550–57. https://dx.doi.org/10.3201/eid1009.040058. 9. Trottein F., Sokol H. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 2020; 32(3): 107915. https://dx.doi.org/10.1016/j.celrep.2020.107915. 10. Macfarlane S., Dillon J. Microbial biofilms in the human gastrointestinal tract. Appl Microbiol. 2007; 102(5): 87–96. https://dx.doi.org/10.1111/j.1365-2672.2007.03287.x. 11. Щикота А.М., Погонченкова И.В., Турова Е.А. с соавт. Поражение желудочно-кишечного тракта, печени и поджелудочной железы при COVID-19. Доказательная гастроэнтерология. 2021; 10(1): 30–37. [Shchikota A.M., Pogonchenkova I.V., Turova E.A. et al. The defeat of the gastrointestinal tract, liver and pancreas with COVID-19. Dokazatel’naya gastroenterologiya = Evidence-based Gastroenterology. 2021; 10(1): 30–37 (In Russ.)]. https://dx.doi.org/10.17116/dokgastro20211001130. EDN: ILPKPO. 12. Dioscoridi L. Pancreas and coronavirus disease-2019. Pancreas Open J. 2020; 4(1): 11–23. https://dx.doi.org/10.17140/POJ-4-111. 13. Fan Z., Chen L., Li J. et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 2020; 18(7): 1561–66. https://dx.doi.org/10.1016/j.cgh.2020.04.002. 14. Patel K.P., Patel P.A., Vunnam R.R. et al. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. J Clin Virol. 2020; 128: 104386. https://dx.doi.org/10.1016/j.jcv.2020.104386. 15. Cryan J.F., Dinan T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10): 701–12. https://dx.doi.org/10.1038/nrn3346. 16. Martins-Filho P.R., Tavares C.S., Santos V.S. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020; 76: 97–99. https://dx.doi.org/10.1016/j.ejim.2020.04.043. 17. Liu F., Long X., Zhang B. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020; 18(9): 2128–30. https://dx.doi.org/10.1016/j.cgh.2020.04.040. 18. Kow C.S., Hasan S.S. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: A meta-analysis. Intern Med. 2021; 289(1): 125–28. https://dx.doi.org/10.1111/joim.13183. 19. Luxenburger H., Sturm L., Biever P. et al. Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: Coincidence or underestimated risk factor. Intern Med. 2021; 289(1): 121–24. https://dx.doi.org/10.1111/joim.13121. 20. Barlass U., Wiliams B., Dhana K. et al. Marked elevation of lipase in COVID-19 disease: A cohort study. Clin Transl Gastroenterol. 2020; 11(7): e00215. https://dx.doi.org/10.14309/ctg.0000000000000215. 21. Muller J., Gro R., Conzelmann C. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021; 3(2): 149–65. https://dx.doi.org/10.1038/s42255-021-00347-1. 22. Money M.E., Hofmann A.F., Hagey L.R. et al. Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea. Pancreas. 2009; 38(2): 232–33. https://dx.doi.org/10.1097/MPA.0b013e31817c1b36. 23. Aloysius M., Thatti A., Gupta A. et al. COVID-19 presenting as acute pancreatitis. Pancreatology. 2020; 20(5): 1026–27. https://dx.doi.org/10.1016/j.pan.2020.05.003. 24. Baker S.S. Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with COVID-19. Ther Clin Risk Manag. 2019; 4(5): 1079–84. https://dx.doi.org/10.2147/tcrm.s3123. 25. Xu Z., Shi L., Wang Y. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4): 420–22. https://dx.doi.org/10.1016/ S2213-2600(20)30076-X. 26. Ивашкин В.Т., Маев И.В., Охлобыстин А.В. с соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению экзокринной недостаточности поджелудочной железы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28(2): 72–100. [Ivashkin V.T., Maev I.V., Okhlobystin A.V. et al. Clinical guidelines of the Russian gastroenterological association for the diagnosis and treatment of exocrine pancreatic insufficiency. Rossiyskiy zhurnal gastroenterologii, gepatologii i koloproktologii= Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(2): 72–100 (In Russ.)]. https://dx.doi.org/10.22416/1382-4376-2018-28-2-72-100. EDN: XPPIST. 27. Ивашкин В.Т., Шептулин А.А., Зольникова О.Ю. с соавт. Новая коронавирусная инфекция (COVID-19) и система органов пищеварения. Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2020; 30(3): 7–13. [Ivashkin V.T., Sheptulin A.A., Zolnikova O.Yu. et al. Novel coronavirus infection (COVID-19) and the digestive system. Rossiyskiy zhurnal gastroenterologii, gepatologii i koloproktologii= Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020; 30(3): 7–13 (In Russ.)]. https://dx.doi.org/10.22416/1382-4376-2020-30-3-7. EDN: TWEQZK.
About the Autors
Elena Yu. Eremina, Dr. med. habil., professor, head of the Department of propaedeutics of internal diseases, N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68 Bol`shevistskaya Str. E-mail: eeu61@mail.ru
Marina I. Lityushkina, PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases, N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68 Bol`shevistskaya Str. E-mail: litjushkina@rambler.ru. ORCID: https://orcid.org/0000-0002-6098-4158
Olga A. Strokova, PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases,
N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68 Bol`shevistskaya Str. E-mail: strokovaoa@rambler.ru. ORCID: https://orcid.org/0000-0003-2774-327X
Similar Articles
